- Home
- EPRX
as 07-26-2024 4:00pm EST
Stocks
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.
| Founded: | 2011 | Country: | British Columbia, Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 93.0M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 6.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $2.40 - $3.50 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest EUPRAXIA PHARMACEUTICALS INC News
EPRX Breaking Stock News: Dive into EPRX Ticker-Specific Updates for Smart Investing
PR Newswire
19 days ago
Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo
CNW Group
19 days ago
Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo
CNW Group
23 days ago
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024
GuruFocus.com
a month ago
A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
Energy Global
a month ago
ANDRITZ to equip new Silvan hydropower plant in Türkiye
USA TODAY
a month ago
Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
Business Wire
a month ago
Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins
Business Wire
a month ago
Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
Compare EPRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EPRX EUPRAXIA PHARMACEUTICALS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.